Pay in 4 interest-free payments of $6.18 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
such risks were only greater with higher doses of tirzepatide than with placebo or GLP-1RA
Hypoglycemia risk increases when tirzepatide is combined with insulin or sulfonylureas, though the medication alone rarely causes low blood sugar due to its glucose-dependent mechanism
Other diagnoses and medications: Depending on what other diseases or conditions you have been diagnosed with, and what medications you are taking, your dose may need to be adjusted
Headaches and dizziness Headaches affect a meaningful percentage of users on both medications
US$ 28.59
US$ 25.05
)
US$ 23.55
US$ 20.56
US$ 25.93
US$ 20.44
US$ 25.89
